Gen-Plus is a small medium-sized, privately owned company.

Its aim is to discover innovations for contract partners. We 

design formulation and technology concepts for the 

pharmaceutical industry. This includes solid and semisolid dosage 

forms as well as patches and thin films. The range is from the 

early idea to the medicinal product samples (for clinical trials) 

under GMP conditions. Another competence of us is consulting 

services for the pharmaceutical industry.

In addition to NCE formulations for Big Pharma, Gen-Plus creates 

innovative design-arounds and Generics-plus concepts for 

established APIs. There is also substantial number of OTC- and 

dietary supplement-projects in the pipeline. Recently, Gen-Plus  

has started to work on biotech molecules (non-parenteral) and 

liposomes.

In our laboratory (area approximately 1000 m²) are currently 15 

staff members working in formulation and analytics.

Special equipment allows handling of high potent active 

pharmaceutical ingredients. In addition, Gen-Plus has a 

comprehensive quality management system and is licensed for 

handling of narcotics.

We have continuously invested in new technology e.g. Hot Melt 

Extrusion, Lyophilization, Amorphization of APIs, Micro-

/Nanoemulsions etc. 

Recent innovations include alternative technologies based on 

Laser and 2D-/3D-Printing Technology respectively.